EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Scorpius Holdings's enterprise value is $18.58 Mil.
Scorpius Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $7.00 Mil. Therefore, Scorpius Holdings's EV-to-Revenue for today is 2.66.
The historical rank and industry rank for Scorpius Holdings's EV-to-Revenue or its related term are showing as below:
SCPX'
s EV-to-Revenue Range Over the Past 10 Years
Min: -540.05 Med: 7 Max: 7561.62
Current: 2.66
During the past 13 years, the highest EV-to-Revenue of Scorpius Holdings was 7561.62. The lowest was -540.05. And the median was 7.00.
SCPX's EV-to-Revenue is ranked better than 75.26% of 1039
companies
in the Biotechnology industry
Industry Median: 8.18
vs SCPX: 2.66
The historical data trend for Scorpius Holdings's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Scorpius Holdings's EV-to-Revenue
For the Biotechnology subindustry, Scorpius Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scorpius Holdings's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Scorpius Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Scorpius Holdings's EV-to-Revenue falls into.
Scorpius Holdings's current Enterprise Value is $18.58 Mil.
Scorpius Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scorpius Holdings's share price for today is $0.1052.
Scorpius Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.27.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scorpius Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Scorpius Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Scorpius Holdings (Scorpius Holdings) Business Description
NightHawk Biosciences Inc is a commercial-stage company with a fully integrated ecosystem to accelerate the discovery and development of novel therapies that arm the immune system. By leveraging its proprietary platforms, the company is advancing its first-in-class product portfolio with a focus on cancer and inflammatory and infectious diseases. Its current pipeline has categories: Oncology, immunology and molecular biology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SCPX has been successfully added to your 